Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer’s disease: the design of donecopridehttps://pubmed.ncbi.nlm.nih.gov/25793650/
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer’s disease treatmenthttps://pubmed.ncbi.nlm.nih.gov/25157130/
Donecopride, a Swiss army knife with potential against Alzheimer’s diseasehttps://pubmed.ncbi.nlm.nih.gov/31881553/
Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategyhttps://pubmed.ncbi.nlm.nih.gov/33926141/
